|Bid||69.00 x 3100|
|Ask||71.57 x 800|
|Day's Range||68.42 - 70.77|
|52 Week Range||49.26 - 142.11|
|Beta (5Y Monthly)||0.35|
|PE Ratio (TTM)||44.47|
|Earnings Date||Nov 02, 2021 - Nov 08, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||79.25|
Haemonetics (HAE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Haemonetics...
Strong recovery across businesses and strength in plasma franchise benefited Haemonetics (HAE) during the first quarter of fiscal 2022.